Prostate Cancer

It’s still no trip to Disneyland, but brachytherapy techniques are getting better and more accurate, thanks to innovations by companies such as Wakefield, Massachusetts-based Implant Sciences.

In late February, the small-cap public company built a test version of software that will give doctors greater control when embedding seeds that emit variable levels of radiation.

Implant Sciences is taking on industry veteran Varian Medical Systems for a piece of the prostate seed placement software market, which Varian estimates at about $12 million.

The experimental software aims to improve radiation placement by calculating where in the gland to place seeds, and at which radiation levels.

It also allows doctors to get a more detailed look at the radiation pattern by breaking down seed placement across the prostate into eight distinct graphical representations.

Expanding the Limits Gordon Grado, the software project’s princ...

Read more...